MedTrace Logo

TuBerculosis Viability Interregional Study and Agreement on Biological Tests

NCT04968886 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2022-06-28

No results posted yet for this study

Summary

The objective of the present study is to confirm in a multicentric study the utility of our viability test in large cohort of smear-positive pulmonary tuberculosis patients under treatment and to determine if the test could help physicians to discontinue isolation measures in hospital setting.

Conditions

  • Tuberculosis, Pulmonary

Interventions

DIAGNOSTIC_TEST

Diagnostic Test: viability test on sputum and comparision with culture results (reference test)

Diagnostic Test: viability test on sputum and comparision with culture results (reference test)

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Benjamin WYPLOSZ, Ph · Public Assistance of Paris Hospitals (APHP)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2023-12-31
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04968886 on ClinicalTrials.gov